Catalog No.: PC-38775Not For Human Use, Lab Use Only.
CDD-787 is a highly potent, selective BET bromodomain 1 (BET BD1) inhibitor with IC50 of 2.1 and 3.3 nM for BRDT-BD1 and BRD4-BD1, respectively, with high selectivity (>3,000-fold) over BET BD2 proteins.
CDD-787 is a highly potent, selective BET bromodomain 1 (BET BD1) inhibitor with IC50 of 2.1 and 3.3 nM for BRDT-BD1 and BRD4-BD1, respectively, with high selectivity (>3,000-fold) over BET BD2 proteins.
CDD-787 exhibits picomolar inhibition against BRD2-BDT1 (IC50 260 pM), BRD3-BD1 (IC50 130 pM), BRD4-BD1 (IC50 290 pM), and BRDT-BD1 (IC50 220 pM), respectively, in the bromoKdELECT assays.
CDD-787 inhibited cell viability of MV4;11 and MOLM-13 cells with IC50 of 8.3 nM and 16 nM, respectively.
CDD-787 induced G1 arrest and apoptosis in both MV4;11 and MOLM-13 cells, suppressed MYC expression in both cell lines.
